Language

English

Publication Date

5-19-2026

Journal

NPJ Vaccines

DOI

10.1038/s41541-026-01489-7

PMID

42156776

PMCID

PMC13454636

PubMedCentral® Posted Date

5-19-2026

PubMedCentral® Full Text Version

Post-print

Abstract

Although individuals with Down syndrome (DS) remain highly vulnerable to severe infections, vaccination remains underutilized. Here we review, specific to people with DS, the safety and efficacy of vaccination, drivers of susceptibility to infection, and existing and emerging opportunities to improve vaccine response. We find that vaccines are generally safe and immunogenic in individuals with DS, although continued research is essential to improve vaccine efficacy and health outcomes.

Keywords

Diseases, Health care, Immunology, Medical research

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.